GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Inventories, Finished Goods

Progen Co (XKRX:296160) Inventories, Finished Goods : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Inventories, Finished Goods?


Progen Co Inventories, Finished Goods Historical Data

The historical data trend for Progen Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Inventories, Finished Goods Chart

Progen Co Annual Data
Trend Dec23
Inventories, Finished Goods
-

Progen Co Quarterly Data
Dec23 Dec24
Inventories, Finished Goods - -

Progen Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Progen Co Business Description

Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines